Meeting
2019 Supportive Care in Oncology Symposium
Prognostic value of the Memorial Sloan Kettering (MSK) prognostic score (MPS) in pancreatic ductal adenocarcinoma (PDAC).
Authors
Justin Lebenthal
New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY
Justin Lebenthal, Junting Zheng, Paul A. Glare, Eileen Mary O'Reilly, Andrew S. Epstein
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Mental Health and Psychological Well-being,Psychosocial and Spiritual/Cultural Assessment and Management,Models of Care,Patient Reported Outcomes and Patient Experience,Prevention, Assessment, and Management of Disease and Treatment-related Symptoms,Prognostication ,Survivorship and Late Effects of Cancer
Sub Track
Prognostication
Citation
J Clin Oncol 37, 2019 (suppl 31; abstr 133)
DOI
10.1200/JCO.2019.37.31_suppl.133
Abstract #
133
Poster Bd #
E8
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The new prognostic index of advanced gastric cancer using the data from JCOG1013.
First Author: Daisuke Takahari
Poster
2016 Palliative and Supportive Care in Oncology Symposium
A novel scoring system to predict survival in patients with advanced pancreatic adenocarcinoma: The Memorial Prognostic Score (MPS).
First Author: Andrew Chung Yang
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Relationship between inflammatory indexes and Khorana score (KS) with prognosis and survival in pancreatic ductal adenocarcinoma (PDAC).
First Author: Rocío Martín Lozano
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Updated results of a phase 1 study of SEA-CD40, gemcitabine, nab-paclitaxel, and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (PDAC; SGNS40-001).
First Author: Andrew L. Coveler